Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring
Abstract
Share and Cite
Cecchin, E.; Orleni, M.; Gagno, S.; Montico, M.; Peruzzi, E.; Roncato, R.; Gerratana, L.; Corsetti, S.; Puglisi, F.; Toffoli, G.; et al. Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring. Int. J. Mol. Sci. 2024, 25, 10453. https://doi.org/10.3390/ijms251910453
Cecchin E, Orleni M, Gagno S, Montico M, Peruzzi E, Roncato R, Gerratana L, Corsetti S, Puglisi F, Toffoli G, et al. Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring. International Journal of Molecular Sciences. 2024; 25(19):10453. https://doi.org/10.3390/ijms251910453
Chicago/Turabian StyleCecchin, Eleonora, Marco Orleni, Sara Gagno, Marcella Montico, Elena Peruzzi, Rossana Roncato, Lorenzo Gerratana, Serena Corsetti, Fabio Puglisi, Giuseppe Toffoli, and et al. 2024. "Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring" International Journal of Molecular Sciences 25, no. 19: 10453. https://doi.org/10.3390/ijms251910453